Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects
Status:
Completed
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
Double-blind, placebo-controlled, First-in-Human, single ascending-dose study. Approximately
40 healthy adult male subjects will be given a single capsule of MYMD1 to determine its
safety, how well it is tolerated, how the body acts on the experimental drug, and how the
experimental drug acts on the body. This will be based on blood and urine sample analysis and
other physical measurements.